EPO Opposition & USPTO PTAB Proceedings (RECORDING)
There are many parallels between proceedings before the USPTO’s Patent Trial and Appeal Board and opposition proceedings before the European Patent Office. However, stakeholders need to understand the differences between the two types of proceedings in order to achieve successful outcomes in both jurisdictions. In this webinar, Maeve O’Flynn (Finnegan) will talk with in-house counsels Rob Furr and Chris Comiskey to compare and contrast the proceedings. They will address potential synergies and conflicts when proceedings are pending or anticipated in both jurisdictions.
Collins Aerospace, an operating unit of Raytheon Technologies Corporation
Chris Comiskey is IP Counsel for Collins Aerospace, an operating unit of Raytheon Technologies Corporation, where he is counsel for the Digital business while also coordinating consistent IP engagement with IP Counsel across the enterprise. Chris serves as Co-Chair for IPO’s U.S. Post-Grant Review Committee. For the businesses he supports Chris has led IP strategy development and execution in invention harvesting, patent procurement, and post-grant monetization/enforcement/challenge phases.
Chief Counsel - Patents
Koch Industries Inc.
Robert Furr is Chief Counsel – Patents with Koch Companies Public Sector, LLC, in Wilmington, Delaware. Rob is responsible for intellectual property matters for several Koch businesses, including managing a docket of about 1400 patents and applications worldwide. Rob earned his undergraduate degree in chemical engineering from Georgia Tech and his law degree from Rutgers. A former chair of the IP section of the Virginia State Bar and the IPO European Practice Committee, Rob represents IPO on the US Bar – EPO Council for Quality and the EPO’s Standing Advisory Committee on e-Patent Processes.
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Maeve O’Flynn is a European and UK patent attorney in Finnegan’s London office. She has more than a decade of in-house experience, having worked at some of the world’s largest multinational corporations in the oil and chemical industries. She has worked for a range of clients, from startups to multinationals, covering diverse technologies such as cosmetics, sustainable chemistry, and catalysis. Maeve has helped clients develop commercially relevant intellectual property strategies. This includes developing and managing global patent portfolios, provisioning advice regarding trade secrets and defensive publications, and negotiating collaboration and licensing agreements. Maeve has extensive experience preparing and prosecuting patent applications, from the initial invention harvesting sessions through to achieving allowance. She works with clients to assess and value their patent portfolios, and to develop filing strategies that support their commercial aims. She also represents clients at oral proceedings before the European Patent Office, representing both patentee and opponent.